MDxHealth SA (MDXH)

USD 1.72

(-1.15%)

Revenue Summary of MDxHealth SA

  • MDxHealth SA's latest annual revenue in 2023 was 70.19 Million USD , up 89.43% from previous year.
  • MDxHealth SA's latest quarterly revenue in 2024 Q2 was 22.15 Million USD , up 11.72% from previous quarter.
  • MDxHealth SA reported a annual revenue of 37.05 Million USD in annual revenue 2022, up 66.62% from previous year.
  • MDxHealth SA reported a annual revenue of 22.23 Million USD in annual revenue 2021, up 21.05% from previous year.
  • MDxHealth SA reported a quarterly revenue of 22.15 Million USD for 2024 Q2, up 11.72% from previous quarter.
  • MDxHealth SA reported a quarterly revenue of 14.7 Million USD for 2023 Q1, up 14.03% from previous quarter.

Annual Revenue Chart of MDxHealth SA (2023 - 2004)

Historical Annual Revenue of MDxHealth SA (2023 - 2004)

Year Revenue Revenue Growth
2023 70.19 Million USD 89.43%
2022 37.05 Million USD 66.62%
2021 22.23 Million USD 21.05%
2020 18.37 Million USD 55.89%
2019 11.78 Million USD -58.41%
2018 28.33 Million USD -30.04%
2017 40.5 Million USD 35.63%
2016 29.86 Million USD 70.99%
2015 17.46 Million USD 52.16%
2014 11.47 Million USD 51.96%
2013 7.55 Million USD 53.59%
2012 4.91 Million USD 41.23%
2011 3.48 Million USD 3.26%
2010 3.37 Million USD -7.61%
2009 3.65 Million USD -13.28%
2008 4.2 Million USD 9.33%
2007 3.85 Million USD 5.29%
2006 3.65 Million USD 0.22%
2005 3.64 Million USD 593.79%
2004 525.97 Thousand USD 0.0%

Peer Revenue Comparison of MDxHealth SA

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -124.625%
Applied DNA Sciences, Inc. 13.36 Million USD -425.104%
Aspira Women's Health Inc. 9.15 Million USD -666.801%
Biodesix, Inc. 49.08 Million USD -42.997%
BioNexus Gene Lab Corp. 9.77 Million USD -618.395%
bioAffinity Technologies, Inc. 2.53 Million USD -2671.689%
bioAffinity Technologies, Inc. 2.53 Million USD -2671.689%
Bionano Genomics, Inc. 36.11 Million USD -94.354%
CareDx, Inc 280.32 Million USD 74.96%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 219.78 Million USD 68.063%
DarioHealth Corp. 20.35 Million USD -244.895%
Exact Sciences Corporation 2.49 Billion USD 97.192%
Fulgent Genetics, Inc. 289.21 Million USD 75.73%
Guardant Health, Inc. 563.94 Million USD 87.553%
ICON Public Limited Company 8.12 Billion USD 99.136%
IDEXX Laboratories, Inc. 3.66 Billion USD 98.083%
Illumina, Inc. 4.5 Billion USD 98.442%
Intelligent Bio Solutions Inc. 3.11 Million USD -2155.718%
iSpecimen Inc. 9.92 Million USD -607.007%
Standard BioTools Inc. 106.34 Million USD 33.992%
23andMe Holding Co. 219.63 Million USD 68.042%
Medpace Holdings, Inc. 1.88 Billion USD 96.278%
Myriad Genetics, Inc. 678.4 Million USD 89.653%
Mainz Biomed B.V. 895.47 Thousand USD -7738.598%
ENDRA Life Sciences Inc. - USD -Infinity%
NeoGenomics, Inc. 591.64 Million USD 88.136%
Neogen Corporation 924.22 Million USD 92.405%
Inotiv, Inc. 572.42 Million USD 87.738%
Natera, Inc. 1.08 Billion USD 93.516%
OPKO Health, Inc. 863.49 Million USD 91.871%
Psychemedics Corporation 22.09 Million USD -217.644%
Prenetics Global Limited 21.74 Million USD -222.835%
Prenetics Global Limited 21.74 Million USD -222.835%
Precipio, Inc. 15.19 Million USD -361.887%
Personalis, Inc. 73.48 Million USD 4.475%
RadNet, Inc. 1.61 Billion USD 95.658%
Sera Prognostics, Inc. 306 Thousand USD -22838.889%
Sotera Health Company 1.04 Billion USD 93.31%
Neuronetics, Inc. 71.34 Million USD 1.619%
Star Equity Holdings, Inc. 45.78 Million USD -53.31%
Star Equity Holdings, Inc. 45.78 Million USD -53.31%
Trinity Biotech plc 56.83 Million USD -23.51%
Twist Bioscience Corporation 312.97 Million USD 77.572%
Exagen Inc. 52.54 Million USD -33.579%